A detailed history of Atlas Private Wealth Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Atlas Private Wealth Advisors holds 4,700 shares of ABBV stock, worth $800,645. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,700
Previous 4,693 0.15%
Holding current value
$800,645
Previous $804,000 15.42%
% of portfolio
0.14%
Previous 0.13%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $1,146 - $1,395
7 Added 0.15%
4,700 $928,000
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $363,756 - $424,786
2,350 Added 100.3%
4,693 $804,000
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $333,224 - $379,678
-2,085 Reduced 47.09%
2,343 $426,000
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $91,091 - $102,590
-662 Reduced 13.01%
4,428 $686,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $299,375 - $346,570
2,241 Added 78.66%
5,090 $758,000
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $159,807 - $198,869
1,206 Added 73.4%
2,849 $383,000
Q1 2023

Apr 12, 2023

BUY
$144.61 - $166.54 $27,909 - $32,142
193 Added 13.31%
1,643 $261,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $200,549 - $240,511
1,450 New
1,450 $234,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $175,144 - $200,878
-1,305 Closed
0 $0
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $137 - $174
1 Added 0.08%
1,305 $200,000
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $172,101 - $213,530
1,304 New
1,304 $211,000
Q4 2021

Apr 21, 2022

SELL
$107.43 - $135.93 $141,807 - $179,427
-1,320 Closed
0 $0
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $2,128 - $2,415
20 Added 1.54%
1,320 $142,000
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $19,253 - $21,449
183 Added 16.38%
1,300 $146,000
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $15,754 - $17,343
154 Added 15.99%
1,117 $121,000
Q3 2020

Oct 27, 2020

BUY
$85.91 - $100.83 $17,182 - $20,166
200 Added 26.21%
963 $84,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $55,981 - $74,911
763 New
763 $75,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Atlas Private Wealth Advisors Portfolio

Follow Atlas Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Private Wealth Advisors with notifications on news.